Page last updated: 2024-08-22

lutetium and (dtpa-phe(1))-octreotide

lutetium has been researched along with (dtpa-phe(1))-octreotide in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
de Jong, M; Esser, JP; Krenning, EP; Kwekkeboom, DJ; Teunissen, JJ; Valkema, R	1

Reviews

1 review(s) available for lutetium and (dtpa-phe(1))-octreotide

Article	Year
Endocrine tumours of the gastrointestinal tract. Peptide receptor radionuclide therapy. Best practice & research. Clinical gastroenterology, 2005, Volume: 19, Issue:4 Topics: Animals; Carcinoma, Neuroendocrine; Gastrointestinal Neoplasms; Humans; Indium Radioisotopes; Lutetium; Octreotide; Organometallic Compounds; Pancreatic Neoplasms; Patient Selection; Pentetic Acid; Peptides, Cyclic; Quality of Life; Radionuclide Imaging; Radiopharmaceuticals; Receptors, Peptide; Receptors, Somatostatin; Somatostatin; Treatment Outcome; Yttrium Radioisotopes	2005

Article

Year

Endocrine tumours of the gastrointestinal tract. Peptide receptor radionuclide therapy.

Best practice & research. Clinical gastroenterology, 2005, Volume: 19, Issue:4

Topics: Animals; Carcinoma, Neuroendocrine; Gastrointestinal Neoplasms; Humans; Indium Radioisotopes; Lutetium; Octreotide; Organometallic Compounds; Pancreatic Neoplasms; Patient Selection; Pentetic Acid; Peptides, Cyclic; Quality of Life; Radionuclide Imaging; Radiopharmaceuticals; Receptors, Peptide; Receptors, Somatostatin; Somatostatin; Treatment Outcome; Yttrium Radioisotopes

2005